PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1627931
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1627931
E-pharmacy Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
The Global e-Pharmacy Market, valued at USD 86.2 billion in 2023, is projected to expand at a robust CAGR of 13.3% from 2024 to 2032. E-pharmacies are online platforms where consumers can easily purchase prescription and over-the-counter (OTC) medications and healthcare products and access related services. These digital platforms offer unparalleled convenience, privacy, and accessibility, allowing customers to have medications delivered directly to their doorsteps.
This market is growing rapidly, driven by the increasing demand for convenient, accessible healthcare solutions. The expansion of internet connectivity, widespread smartphone adoption, and a growing preference for digital health services have significantly simplified the process of accessing medications online. This shift is particularly evident in managing chronic conditions and recurring prescriptions, which are increasingly handled through e-pharmacies.
The market is divided into two categories: OTC products and prescription medicines. OTC products lead the market and are expected to grow at a steady rate of 12.6% CAGR over the coming years. The dominance of OTC products can be attributed to a growing consumer preference for self-medication and the convenience of purchasing medicines without a prescription. With a variety of easily accessible medications available online, consumers are increasingly turning to e-pharmacies for their OTC needs. The rising prevalence of chronic health conditions and the aging population drive the demand for OTC products. Additionally, the discreet nature of online purchases and the added convenience of home delivery fuel this growth.
| Market Scope | |
|---|---|
| Start Year | 2023 |
| Forecast Year | 2024-2032 |
| Start Value | $86.2 Billion |
| Forecast Value | $263.3 Billion |
| CAGR | 13.3% |
The United States maintains a dominant position in the North American e-pharmacy market and is expected to continue leading throughout the forecast period. The country benefits from a strong healthcare infrastructure, a well-established regulatory framework, and high adoption rates of digital health solutions. The popularity of online prescription services, in line with the convenience of having medications delivered to one's home, has significantly contributed to the widespread adoption of e-pharmacies. The ongoing advancements in digital health technology and the growing focus on improving patient care ensure that the U.S. will remain a key player in the global e-pharmacy market.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definition
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Rise in the number of internet users worldwide
- 3.2.1.2 Increasing access to web-based and online services
- 3.2.1.3 Lucrative offers and discounts along with easy availability of online prescription drugs
- 3.2.1.4 Expanding geriatric population base coupled with growing prevalence of chronic disorders
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Increasing number of illegal online pharmacies
- 3.2.2.2 Risk of counterfeit drugs
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.4.1 U.S.
- 3.4.2 Europe
- 3.5 Current and future scenario of online pharmacies
- 3.6 E-pharmacy market script volume, by payer mix, 2021-2032
- 3.7 E-pharmacy business models
- 3.8 Bifurcation between OTC and Rx
- 3.9 Porter's analysis
- 3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company matrix analysis
- 4.3 Company market share analysis
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix
- 4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 OTC products
- 5.3 Prescription medicine
Chapter 6 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 North America
- 6.2.1 U.S.
- 6.2.2 Canada
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 UK
- 6.3.3 France
- 6.3.4 Spain
- 6.3.5 Italy
- 6.3.6 Russia
- 6.3.7 Belgium
- 6.3.8 Netherlands
- 6.3.9 Norway
- 6.3.10 Switzerland
- 6.4 Asia Pacific
- 6.4.1 Japan
- 6.4.2 China
- 6.4.3 India
- 6.4.4 Australia
- 6.4.5 South Korea
- 6.4.6 Indonesia
- 6.4.7 New Zealand
- 6.4.8 Singapore
- 6.4.9 Thailand
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Mexico
- 6.5.3 Argentina
- 6.5.4 Colombia
- 6.5.5 Chile
- 6.6 Middle East and Africa
- 6.6.1 South Africa
- 6.6.2 Saudi Arabia
- 6.6.3 UAE
- 6.6.4 Egypt
- 6.6.5 Iran
Chapter 7 Company Profiles
- 7.1 Capsule
- 7.2 Alto Pharmacy
- 7.3 Amazon
- 7.4 CVS Health
- 7.5 Express Scripts Holdings (Cigna)
- 7.6 Giant Eagle
- 7.7 MedsEngage
- 7.8 Optum Rx (UnitedHealth Group)
- 7.9 Rite Aid
- 7.10 The Kroger
- 7.11 Walgreens Boots Alliance
- 7.12 Walmart
